HOUSTON (May 27, 2022)

The rectal cancer program at Memorial Hermann Memorial City Medical Center has been awarded accreditation by the National Accreditation Program for Rectal Cancer (NAPRC).

The NAPRC was developed through a collaboration between the OSTRiCh Consortium (Optimizing the Surgical Treatment of Rectal Cancer) and the Commission on Cancer (CoC), a quality program of the American College of Surgeons. The NAPRC’s goal is to ensure patients with rectal cancer receive appropriate care using a multidisciplinary approach.

“We are honored to earn this distinction for multiple Memorial Hermann campuses,” said Sandra Miller, Vice President of the Oncology Service Line at Memorial Hermann Health System. “The NAPRC emphasizes important factors such as program management, clinical services and quality improvement, so this distinction reassures that we are providing our patients with the highest quality of care possible.”

“Memorial Hermann and the doctors at UT Health are extremely happy to now have three centers of excellence for treatment of rectal cancer,” said Dr. Joseph Cali, Jr., who is an Assistant Professor of Surgery at McGovern Medical School at UTHealth Houston. He also is the Memorial Hermann Health System Rectal Cancer Director and the Rectal Cancer Program Director at Memorial Hermann Memorial City Medical Center. “These centers of excellence follow the nationally set standards by the American College of Surgeons for the treatment of rectal cancer.”

Last fall, the rectal cancer programs at both Memorial Hermann The Woodlands Medical Center and Memorial Hermann Southeast Hospital were also awarded the same accreditation by the NAPRC. The programs are among only 56 nationwide accredited by the NAPRC.

Accreditation by the NAPRC is granted only to those programs that are voluntarily committed to providing the best possible care to patients with rectal cancer. Each rectal cancer program must undergo a rigorous evaluation and review of its performance and compliance with NAPRC Standards.